Final overall survival analysis of a phase II trial evaluating vinorelbine and lapatinib in women with ErbB2 overexpressing metastatic breast cancer

Wolfgang Janni, Christos Papadimitriou, Bogusława Karaszewska et al.|The Breast|2015

Cited by 11